Dysfunctional Uterine Bleeding Market Estimated to Inflate with a Decent CAGR of ~8.2% by 2023; Asserts MRFR


Pune, India — 11/24/2017 — The Worldwide Dysfunctional Uterine Bleeding Market research report is growing with the rapid pace; mainly due the burgeoning Healthcare Sector. According to a recent study report published by the Market Research Future, The World Dysfunctional Uterine Bleeding Industry Research report is booming and expected to gain prominence over the forecast period. The Market is forecasted to demonstrate a huge growth by 2023, surpassing its previous growth records in terms of value & volume. Considering all these factors The World Dysfunctional Uterine Bleeding Market research report is expected to grow at a CAGR of 8.2% during the forecast period.

Market Research Future published new report, titled “Dysfunctional Uterine Bleeding Market -Research Report: Global Forecast till 2023″.

The Worldwide Dysfunctional Uterine Bleeding Market report explores the Top Key Players in-depth analysis as: B. Braun Melsungen AG (Germany), Hologic Inc. (U.S.), Karl Storz Gmbh & Co. KG (Germany), Medgyn Products, Inc., Olympus (Japan), Richard Wolf GmbH (Germany), Stryker (U.S.), Xion Medical GmbH (Germany), Cadila Pharmaceuticals Ltd. (India), Torrent Phamraceuticals (India).

Market Synopsis of Global Dysfunctional Uterine Bleeding Market:
Dysfunctional uterine bleeding, also known as abnormal uterine bleeding, is irregular bleeding occurring in the absence of any recognizable pelvic pathology. Pregnancy is a common cause of abnormal uterine bleeding. The main causes of uterine bleeding can be fibroids in the uterus, infection of the cervix, and cancer of the uterus in some cases. Medications causing dysfunctional uterine bleeding are birth control pills, hormonal agents, and Coumadin.

Rising prevalence of uterine disorders such as uterine cancer, polycystic ovary syndrome, endometriosis, and uterine polyps drive the market growth. Furthermore, rising prevalence of uterine cancer, and demand for diagnosis and treatment measures also influence the market growth. According to the Cancer Research, in 2014, 9324 new cases of uterine cancer were diagnosed in U.K and the number is expected to increase in the near future.
According to the World Cancer Research Fund International, endometrial cancer is the sixth most common cancer in women worldwide, with 320,000 new cases diagnosed in 2012. It also stated that about 53% of endometrial cancer cases occurred in the developed countries.

Market Segments:
The global dysfunctional uterine bleeding market is segmented on the basis of type, diagnosis, treatment, and end user.
On the basis of type, market is segmented into ovulatory, and anovulatory.
On the basis of diagnosis, the market is segmented into hysteroscopy, ultrasonography, dilation and curettage, endometrial biopsy, and others.
On the basis of treatment, the market is segmented into pharmacologic treatment, hysterectomy, endometrial ablation, and others. The pharmacologic treatment includes oral contraceptives, estrogen, progestins, desmopressin and others.
On the basis of end user, the market is segmented into hospitals, clinics, diagnostic centers, pharmaceutical companies, and others.

GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/4685 .

Regional Analysis:
America is the largest market for dysfunctional uterine bleeding market across the globe. The market is driven by the rising prevalence of uterine cancer and other uterine disorders among women. According to the American Cancer Institute, about 61,380 new cases of uterine cancer is estimated to be diagnosed in 2017.
Europe is the second largest market owing to an increasing demand for diagnosis and treatment measures for uterine cancer, fibroids and other disorders, and increasing emphasis on women healthcare.

The market in Asia Pacific is expected to grow at the fastest pace and is driven by the increasing prevalence of menstrual disorders, rising awareness about causes of such disorders and early diagnosis and treatment measures among women. The market is also driven by rising prevalence of sexually transmitted diseases among women in the developing nations.

The Middle East & Africa also show a steady rise in the market owing to increasing focus on women and child health, and need of primary care services in developing regions.

Table of Contents
Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Dysfunctional Uterine Bleeding Market, By Type

Chapter 7. Global Dysfunctional Uterine Bleeding Market, By Diagnosis

Chapter 8. Global Dysfunctional Uterine Bleeding Market, By Treatment

Chapter 9. Global Dysfunctional Uterine Bleeding Market, By End User

Chapter 10. Global Dysfunctional Uterine Bleeding Market, By Region

Chapter 11. Company Landscape

Chapter 12. Company Profiles

Chapter 13. MRFR Conclusion

Chapter 14. Appendix


GET DISCOUNT @ https://www.marketresearchfuture.com/check-discount/4685 .

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]

Powered by WPeMatico